分類: 技術轉移招商
技術轉移招商en文章
閱讀更多 →
NHRI technology, “Influenza vaccine production using suspension MDCK (NHRI sMDCK) cells” (abbreviated as “The Technology”) available for technology licensing.(2019/12/4)
Description The licensing technology is about a proprietary Madin-Darby canine kidney cell line (NHRI sMDCK) capable of growing in suspension culture without serum. Further disclosed …
技術轉移招商en文章
閱讀更多 →
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR807: a CXCR4-Targeted Antagonist”(2019/07/24)
Title: NHRI technology, “DBPR807: a CXCR4-Targeted Antagonist” (abbreviated as “The Technology”) available for industry-academia collaboration or technology licensing. Description: DBPR807 is a potent antagonist targeting …
技術轉移招商en文章
閱讀更多 →
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR215: A Stem Cell Mobilizer for Cell Based Therapy”(2019/07/24)
Title: NHRI technology, “DBPR215: A Stem Cell Mobilizer for Cell Based Therapy” (abbreviated as “The Technology”) available for industry-academia collaboration technology licensing. Description: DBPR807 is …
